Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
Patients with chemotherapy-induced febrile neutropenia (CIFN) may have changes in the pharmacokinetics (PK) compared to patients without malignancies or neutropenia. Those changes in antibiotic PK could lead to negative outcomes for patients if the therapy is not adequately adjusted to this. In this...
Saved in:
Main Authors: | José C. Álvarez (Author), Sonia I. Cuervo (Author), Edelberto Silva (Author), Jorge A. Díaz (Author), Lorena L. Jiménez (Author), Daniel S. Parra (Author), Julio C. Gómez (Author), Ricardo Sánchez (Author), Jorge A. Cortés (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of Vancomycin among Patients with Chemotherapy-Associated Febrile Neutropenia: Which Would Be the Best Dosing to Obtain Appropriate Exposure?
by: Daniel Parra González, et al.
Published: (2022) -
Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy - a real-life experience
by: Najmul Karim, et al.
Published: (2022) -
Altered Pharmacokinetics Parameters of Vancomycin in Patients with Hematological Malignancy with Febrile Neutropenia, a Bayesian Software Estimation
by: Abdullah M. Alzahrani, et al.
Published: (2023) -
The risk factors for febrile neutropenia during chemotherapy in children with malignancy
by: Rini Sulviani, et al.
Published: (2007) -
Antimicrobial agent prescription patterns for chemotherapy-induced febrile neutropenia in patients with hematological malignancies at Sultan Qaboos University Hospital, Oman
by: K.A. Al Balushi, et al.
Published: (2013)